Interaction of EGFR 497Arg>Lys with EGF +61A>G Polymorphism: Modulation of risk in esophageal cancer

Oncology Research

Volumn 17, Issue 4, 2008, Pages 167-174

  Upadhyay, Rohit ^a   Jain, Meenu ^a   Kumar, Shaleen ^a   Ghoshal, Uday Chand ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer risk; Cancer susceptibility; EGF EGFR interactions; Esophageal cancer

Indexed keywords

ARGININE; GLYCINE; LYSINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; ESOPHAGUS CANCER; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

EID: 51049111387     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504008785114147     Document Type: Article

References (31)

1. Munoz, N. Epidemiological aspects of oesophageal cancer. Endoscopy 25:609-612; 1993.
2. Vallböhmer, D.; Lenz, H. J. Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis. Esophagus 19:425-432; 2006.
3. Martin, I. G.; Young, S.; Sue-Ling, H.; Johnston, D. Delays in the diagnosis of oesophagogastric cancer: A consecutive case series. BMJ 314:467-470; 1997.
4. Mendelsohn, J.; Baselga, J. The EGF receptor family as targets for cancer therapy. Oncogene 19:6550-6565; 2000.
5. Moriai, T.; Kobrin, M. S.; Hope, C.; Speck, L.; Korc, M. A variant epidermal growth factor receptor exhibits altered type alfa transforming growth factor binding and transmembrane signaling. Proc. Natl. Acad. Sci. USA 91: 10217-10221; 1994.
6. Wang, W. S.; Chen, P. M.; Chiou, T. J.; Liu, J. H.; Lin, J. K.; Lin, T. C.; Wang, H. S.; Su, Y. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin. Cancer Res. 13:3597-3604; 2007.
7. Zhang, W.; Park, D. J.; Lu, B.; Yang, D. Y.; Gordon, M.; Groshen, S.; Yun, J.; Press, O. A.; Vallböhmer, D.; Rhodes, K.; Lenz, H. J. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treatment with chemoradiation. Clin. Cancer Res. 11:600-605; 2005.
8. Salomon, D. S.; Brandt, R.; Ciardiello, F.; Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19:183-232; 1995.
9. Shahbazi, M.; Pravica, V.; Nasreen, N.; Fakhoury, H.; Fryer, A. A.; Strange, R. C.; Hutchinson, P. E.; Osborne, J. E.; Lear, J. T.; Smith, A. G.; Hutchinson, I. V. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359:397-401; 2002.
10. Amend, K. L.; Elder, J. T.; Tomsho, L. P.; Bonner, J. D.; Johnson, T. M.; Schwartz, J.; Berwick, M.; Gruber, S. B. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res. 64:2668-2672; 2004.
11. Lazar-Molnar, E.; Hegyesi, H.; Toth, S.; Falus, A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12:547-554; 2000.
12. McCarron, S. L.; Bateman, A. C.; Theaker, J. M.; Howell, W. M. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int. J. Cancer 107:673-675; 2003.
13. Goto, Y.; Ando, T.; Goto, H.; Hamajima, N. No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol. Biomarkers Prev. 14:2454-2456; 2005.
14. Hamai, Y.; Matsumura, S.; Matsusaki, K.; Kitadai, Y.; Yoshida, K.; Yamaguchi, Y.; Imai, K.; Nakachi, K.; Toge, T.; Yasui, W. Single nucleotide polymorphism in the 5′ untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 72:133-138; 2005.
15. Jain, M.; Kumar, S.; Lal, P.; Tiwari, A.; Ghoshal, U. C.; Mittal, B. Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol. Biomarkers Prev. 16:178-181; 2007.
16. Miller, S. A.; Dykes, D. D.; Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 116:1215; 1988.
17. Jain, M.; Kumar, S.; Rastogi, N.; Lal, P.; Ghoshal, U. C.; Tiwari, A.; Pant, M. C.; Baiq, M. Q.; Mittal, B. GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett. 242:60-67; 2006.
18. Martin, K.; Radlmayr, M.; Borchers, R.; Heinzlmann, M.; Folwaczny, C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 66:121-126; 2002.
19. Bandrés, E.; Barricarte, R.; Cantero, C.; Honorato, B.; Malumbres, R.; Zárate, R.; Alcalde, J.; García-Foncillas, J. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients. Oral Oncol. 43:713-719; 2007.
20. Gibault, L.; Metges, J. P.; Conan-Charlet, V.; Lozac'h, P.; Robaszkiewicz, M.; Bessaguet, C.; Lagarde, N.; Volant, A. Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer. Br. J. Cancer 93: 107-115; 2005.
21. Bhowmick, D. A.; Zhuang, Z.; Wait, S. D.; Weil, R. J. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res. 64:1220-1223; 2004.
22. Chitra, S.; Ashok, L.; Anand, L.; Srinivasan, V.; Jayanthi, V. Risk factors for esophageal cancer in Coimbatore, southern India: A hospital-based case-control study. Indian J. Gastroenterol. 23:19-21; 2004.
23. Chiu, B.; Mirkin, B.; Madonna, M. B. Mitogenic and apoptotic actions of epidermal growth factor on neuroblastoma cells are concentration-dependent. J. Surg. Res. 135: 209-212; 2006.
24. Lam, A. K. Molecular biology of esophageal squamous cell carcinoma. Crit. Rev. Oncol. Hematol. 33:71-90; 2000.
25. Walch, A.; Mueller, J.; Hofler, H.; Werner, M. Re: Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J. Natl. Cancer Inst. 14:1182-1183; 2000.
26. Mukaida, H.; Yamamoto, T.; Hirai, T.; Toi, M.; Nakamura, T.; Wada, T.; Yamashita, Y.; Kawano, K.; Niimoto, M. Expression of human epidermal growth factor and its receptor in esophageal cancer. Jpn. J. Surg. 20:275-282; 1990.
27. Monteiro, E.; Varzim, G.; Pires, A. M.; Teixeira, M.; Lopes, C. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: Implications of tumor localization and tobacco exposure. Cancer Detect. Prev. 28:237-243; 2004.
28. van Leeuwen, D. M.; van Agen, E.; Gottschalk, R. W.; Vlietinck, R.; Gielen, M.; van Herwijnen, M. H.; Maas, L. M.; Kleinjans, J. C.; van Delft, J. H. Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. Carcinogenesis 28:691-697; 2007.
29. Cordell, H. J.; Todd, J. A.; Hill, N. J.; Lord, C. J.; Lyons, P. A.; Peterson, L. B.; Wicker, L. S.; Clayton, D. G. Statistical modeling of interlocus interactions in a complex disease: Rejection of the multiplicative model of epistasis in type I diabetes. Genetics 158:357-367; 2001.
30. Arnold, D.; Peinert, S.; Voigt, W.; Schmoll, H. J. Epidermal growth factor receptor tyrosine kinase inhibitors: Present and future role in gastrointestinal cancer treatment: A aeview. Oncologist 11:602-611; 2006.
31. Tabernero, J.; Macarulla, T.; Ramos, F. J.; Baselga, J. Novel targeted therapies in the treatment of gastric and esophageal cancer. Ann. Oncol. 16:1740-1748; 2005.